| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,649 |
8,076 |
$617K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,455 |
4,440 |
$149K |
| 90461 |
|
1,577 |
1,573 |
$68K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
871 |
870 |
$58K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
696 |
696 |
$47K |
| 87428 |
|
1,114 |
1,089 |
$39K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
516 |
516 |
$38K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
528 |
506 |
$35K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
388 |
368 |
$20K |
| 81001 |
|
2,927 |
2,912 |
$7K |
| 87430 |
|
592 |
580 |
$6K |
| 92552 |
|
249 |
248 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
250 |
211 |
$3K |
| 96127 |
|
592 |
590 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
342 |
333 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
30 |
29 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
190 |
183 |
$1K |
| 0071A |
|
18 |
18 |
$855.88 |
| 99441 |
|
65 |
59 |
$817.41 |
| 99429 |
|
34 |
34 |
$801.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
164 |
164 |
$625.00 |
| 0072A |
|
12 |
12 |
$555.88 |
| 94010 |
|
13 |
13 |
$314.29 |
| 96160 |
|
524 |
521 |
$226.93 |
| 85018 |
|
111 |
111 |
$189.54 |
| 83655 |
|
12 |
12 |
$105.38 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
14 |
14 |
$71.72 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
857 |
837 |
$36.00 |
| 90686 |
|
1,274 |
1,269 |
$22.35 |
| 36416 |
|
13 |
13 |
$18.18 |
| 99173 |
|
139 |
139 |
$1.80 |
| 1036F |
|
151 |
151 |
$0.00 |
| 91307 |
|
37 |
31 |
$0.00 |
| 90619 |
|
16 |
16 |
$0.00 |
| 90696 |
|
15 |
15 |
$0.00 |
| 99072 |
|
1,436 |
1,371 |
$0.00 |
| 90715 |
|
25 |
24 |
$0.00 |
| 90670 |
|
153 |
153 |
$0.00 |
| 90649 |
|
30 |
30 |
$0.00 |
| 90685 |
|
14 |
14 |
$0.00 |
| 90734 |
|
42 |
42 |
$0.00 |
| 90658 |
|
13 |
13 |
$0.00 |